Chimeric antigen receptor tumor infiltrating lymphocytes
A lymphocyte and tumor infiltration technology, applied in the direction of anti-tumor drugs, animal cells, antibody medical components, etc., can solve the problem that PBL cannot penetrate solid tumor blocks, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0132] Figure 1A Cr for TILs against MC-38 is shown 51 Release assay. Figure 1B MC-38 tumor volumes in mice receiving TIL are shown. Figure 1C It was shown that TILs tracked by CD45.2 staining are preferentially retrafficked back to MC-38 tumors.
Embodiment 2
[0134] MC38 tumors were generated in donor mice (CD45.2+) by subcutaneous injection of tumor cell suspension. Once tumors were formed, CD45.2+ TILs were isolated and expanded ex vivo in the presence of IL-2. These were injected into tumor bearing recipient mice (CD45.1+). The tissue distribution of adoptively transferred TILs was tracked by flow cytometry due to the expression of CD45.2.
[0135] Using this method, adoptively transferred TILs (CD3+CD45.2+) were observed to be gradually enriched in tumors over the course of one week ( figure 2 ). The majority of metastatic TILs relocalized to recipient mouse tumors were CD8+ T cells ( figure 2 ).
[0136] Although a small fraction of adoptively transferred TILs was transiently detected in the spleen, lymph nodes, and bone marrow of recipient mice on day 1; by day 7 post-infusion, nearly all transferred TILs (and all CD8+ transferred TILs) are transported to the tumor ( image 3 ). The results indicated that TI...
Embodiment 3
[0141] Tumor infiltrating lymphocytes from melanoma patients were expanded in the presence of IL-2 following standard procedures. Forty-eight hours after REP, cells were transduced with a retroviral vector encoding an anti-IL13RA2 CAR (Hu07-28z). Transduction was repeated one day later, and CAR expression was assessed by flow cytometry after staining with biotinylated protein-L and PE-conjugated streptavidin ( Figure 5 ).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com